Bernu Kliniska Universitates Slimnica VSIA

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia2 trials
• Childhood cancers2 trials
• Multiple sclerosis2 trials
• Asthma1 trial
• Cerebral palsy1 trial
• Turner syndrome1 trial

Phase

• Phase 36 trials
• Phase 21 trial

Status

• Active, not recruiting4 trials
• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Hoffmann-La Roche1 trial
• Merz Pharmaceuticals GmbH1 trial
• Novartis Pharma AG1 trial
• Novo Nordisk A/S1 trial
• Princess Maxima Center for Pediatric Oncology1 trial
• and 2 more

Running trials

• Recruiting

  CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients

  NCT06262438· Phase 2· Princess Maxima Center for Pediatric Oncology· Source

• Active, not recruiting

  A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

  NCT06052267· Phase 3· Teva Branded Pharmaceutical Products R&D LLC· Source

• Recruiting

  CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)

  2023-504999-25-00· Phase 3· Prinses Maxima Centrum voor Kinderoncologie B.V.· Source

• Active, not recruiting

  A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

  NCT05330325· Phase 3· Novo Nordisk A/S· Source

• Active, not recruiting

  A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

  NCT05123703· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis

  2024-511686-11-00· Phase 3· Novartis Pharma AG· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia2 recruiting
• Childhood cancers2 recruiting

Closed trials

• Completed

  A clinical study to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity in children and adolescents with cerebral palsy.

  2023-503420-19-00· Phase 3· Merz Pharmaceuticals GmbH· Source